image: New research from the Journal of Medicinal Chemistry may help millions stick to a common resolution: quitting smoking. Researchers at the Scripps Institute in La Jolla, California, are working on a nicotine vaccine that could put an end to the addiction. Kim Janda, Ph.D.'s approach is to get the body's immune system to treat nicotine like a foreign invader. But getting the body to respond in the right way is a big challenge. The video, the first from the newly launched ACS Headline Science series, is available at http://youtu.be/jfbL8quK3a0. view more
Credit: The American Chemical Society
WASHINGTON, Jan. 21, 2015 -- New research from the Journal of Medicinal Chemistry may help millions stick to a common resolution: quitting smoking. Researchers at the Scripps Institute in La Jolla, California, are working on a nicotine vaccine that could put an end to the addiction. Kim Janda, Ph.D.'s approach is to get the body's immune system to treat nicotine like a foreign invader. But getting the body to respond in the right way is a big challenge. The video, the first from the newly launched ACS Headline Science series, is available at http://youtu.be/jfbL8quK3a0.
Subscribe to the ACS channel at http://bit.ly/ACSYoutube and follow us on Twitter @ACSPressroom.
###
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 161,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.